Tobias F Dreyer

8PUBLICATIONS
42CO-AUTHORS
Predictive and prognostic markersMedical infection agents (incl. prions)Haematological tumoursCancer geneticsMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Oct 27, 2026
Kallikrein-Related Peptidase 5 Is Associated with Tumor Progression, KRT19 Expression, and Distinct Molecular Programs in High-Grade Serous Ovarian Cancer.

|Sep 25, 2026
Herpes simplex virus and kallikrein-related peptidases - a functional connection in Alzheimer's disease.

|Apr 24, 2026
High uPAR and Low miR-221 Expression Predict Poor Disease-Free Survival in Triple-Negative Breast Cancer.

|Jan 10, 2026
Drug Discovery Strategies for Kallikrein-Related Peptidases.

Tobias Dreyer, Daniela Schuster, Viktor Magdolen

|Oct 30, 2024
Expert-Guided Large Language Models for Clinical Decision Support in Precision Oncology.

Jacqueline Lammert, Tobias Dreyer, Sonja Mathes

|Oct 27, 2022
A Pair of Prognostic Biomarkers in Triple-Negative Breast Cancer: KLK10 and KLK11 mRNA Expression.

Yueyang Liu, Weiwei Gong, Sarah Preis

Pageof 2

Frequent Collaborators

6 joint publications

Viktor Magdolen

5 joint publications

Marion Kiechle

2 joint publications

Holger Bronger

1 joint publications

Brian W-C Tse